SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-16-005288
Filing Date
2016-04-01
Accepted
2016-04-01 16:30:49
Documents
7
Period of Report
2016-05-17
Effectiveness Date
2016-04-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT geron_def14a.htm DEF 14A 701897
2 GRAPHIC geron_def14a1x1x1.jpg GRAPHIC 4601
3 GRAPHIC geron_def14a1x1x2.jpg GRAPHIC 9352
4 GRAPHIC geron_def14a1x2x1.jpg GRAPHIC 4708
5 GRAPHIC geron_def14a1x2x2.jpg GRAPHIC 8046
6 GRAPHIC geron_def14a5x12x1.jpg GRAPHIC 9221
7 GRAPHIC proxyx1x1.jpg GRAPHIC 6984
  Complete submission text file 0001206774-16-005288.txt   763056
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 161547622
SIC: 2834 Pharmaceutical Preparations